Novel, biocompatible, and disease modifying VIP nanomedicine for rheumatoid arthritis
about
Nanomedicine delivers promising treatments for rheumatoid arthritisThe dendritic cell response to classic, emerging, and homeostatic danger signals. Implications for autoimmunityA new lipid-based nano formulation of vinorelbineSympathetic Neurotransmitters Modulate Osteoclastogenesis and Osteoclast Activity in the Context of Collagen-Induced ArthritisParticle-based technologies for osteoarthritis detection and therapy.A novel peptide nanomedicine for treatment of pancreatogenic diabetes.Solubilization of therapeutic agents in micellar nanomedicines.Polymer-based vehicles for therapeutic peptide delivery.Vasoactive Intestinal Peptide Nanomedicine for the Management of Inflammatory Bowel Disease.Do Neuroendocrine Peptides and Their Receptors Qualify as Novel Therapeutic Targets in Osteoarthritis?Urokinase plasminogen activator system in synovial fibroblasts from osteoarthritis patients: modulation by inflammatory mediators and neuropeptides.GLP-1 nanomedicine alleviates gut inflammation.When Is It Important to Measure Unbound Drug in Evaluating Nanomedicine Pharmacokinetics?
P2860
Q27021438-9C309658-4F7B-4929-AADF-BBA2CDF1B6C0Q28384138-7EF5018B-0AA0-4329-82D9-E1C92CEA9CEBQ34265212-2933BFA7-64E8-490C-908C-74F3031A353BQ36117189-9F7260BA-9EE8-4405-A5A0-CC001900B558Q36303687-B2FA0363-2C57-41E9-9E4A-3993C11A1688Q36875741-80B01F13-6783-4A3F-AA13-D0606B09F680Q37654928-44521F68-9443-4A04-9BB1-4EF56FFB5FA8Q38645362-275C115D-3BB2-4F30-BC87-BDC98A9F24ECQ47677851-24CF35C9-2176-40C5-8A81-48E73094A2DBQ47709852-0B9ED60E-3772-459A-84BA-BA16A2622DFFQ48120538-41505345-5886-44D0-BD8C-65658CE092E6Q49238813-8E2A634D-D80E-47A7-95F5-57F50A1DFD70Q51460131-7B78771C-1E1D-459E-AA20-2611273814D6
P2860
Novel, biocompatible, and disease modifying VIP nanomedicine for rheumatoid arthritis
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Novel, biocompatible, and disease modifying VIP nanomedicine for rheumatoid arthritis
@ast
Novel, biocompatible, and disease modifying VIP nanomedicine for rheumatoid arthritis
@en
type
label
Novel, biocompatible, and disease modifying VIP nanomedicine for rheumatoid arthritis
@ast
Novel, biocompatible, and disease modifying VIP nanomedicine for rheumatoid arthritis
@en
prefLabel
Novel, biocompatible, and disease modifying VIP nanomedicine for rheumatoid arthritis
@ast
Novel, biocompatible, and disease modifying VIP nanomedicine for rheumatoid arthritis
@en
P2093
P2860
P356
P1476
Novel, biocompatible, and disease modifying VIP nanomedicine for rheumatoid arthritis
@en
P2093
Antonina Kuzmis
Hayat Onyuksel
Helen Kastrissios
Israel Rubinstein
James Artwohl
Varun Sethi
P2860
P304
P356
10.1021/MP300539F
P407
P577
2013-01-23T00:00:00Z